Skip to main content
TipRanks
Go Ultimate75% OFF

Eagle Pharmaceuticals (EGRX) Revenue

213 Followers

Eagle Pharmaceuticals Revenue

Eagle Pharmaceuticals had a revenue of 64.65M in the quarter ending Jun 30, 2023, with -2.50%. This bring the company's revenue in the last twelve months to 257.55M, Decreased 3.55%. In the fiscal year ending Dec 31, 2022, Eagle Pharmaceuticals had annual revenue of 316.61M with 84.56% growth.

Revenue (ttm)
257.55M
Revenue Growth
―
P/S Ratio
0.03
Revenue/Employee
$2,345,259
Employees
135
Market Cap
$10.68M

Revenue Chart

Eagle Pharmaceuticals Revenue - Annual

050M100M150M200M250M300M350M236.71M213.31M195.89M187.80M171.55M316.61M201720182019202020212022
Revenue History
Download to Excel
EGRX revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2022316.61M145.06M84.56%
Dec 31, 2021171.55M-16.26M-8.66%
Dec 31, 2020187.80M-8.09M-4.13%
Dec 31, 2019195.89M-17.42M-8.17%
Dec 31, 2018213.31M-23.39M-9.88%
Dec 31, 2017236.71M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
EGRX257.55M
PCRX743.30M
ANIP1.04B
AMPH745.79M
CPIX25.13M
ETON141.06M